Multiple Sclerosis Newswire (Page 10)

Multiple Sclerosis Newswire (Page 10)

Comprehensive Real-Time News Feed for Multiple Sclerosis. (Page 10)

Results 181 - 200 of 66,262 in Multiple Sclerosis

  1. Biogen Celebrates 40 Years as a Pioneer in NeuroscienceRead the original story w/Photo

    Monday May 14 | Business Wire

    ... Prize winners Walter Gilbert and Phillip Sharp, and today has the leading portfolio of medicines to treat multiple sclerosis; has introduced the first and only approved treatment for spinal muscular atrophy; and is focused on advancing neuroscience ...

    Comment?

  2. Multiple sclerosis in Canada: Understanding why MS rates are the highest hereRead the original story w/Photo

    Monday May 14 | CISN Country 103.9 FM

    This is the first story in a five-part series exploring multiple sclerosis in Canada and the implications the disease has on patients, health care and the country as a whole. Jessica Howe remembers the day her life changed, and the exact feelings and thoughts that ran through her mind.

    Comment?

  3. Global Blood-Brain Barrier Technologies Market Report, Trends, Size,...Read the original story

    Monday May 14 | World News Report

    ... has been segmented into major diseases such as Parkinson's disease, meningitis, Alzheimer's disease, multiple sclerosis and encephalitis. Key players: Allon Therapeutics, Inc., AngioChem Inc., Genzyme, CeNeRx BioPharma, Inc, Bioasis Technologies ...

    Comment?

  4. FDA approves new drug to treat MS in pediatric patientsRead the original story w/Photo

    Monday May 14 | Medical News

    The U.S. Food and Drug Administration today approved Gilenya to treat relapsing multiple sclerosis in children and adolescents age 10 years and older. This is the first FDA approval of a drug to treat MS in pediatric patients.

    Comment?

  5. Medical Marijuana Market 2018-2025, By Types (Migraine, Arthritis,...Read the original story

    Monday May 14 | Emailwire.com

    ... current available treatment approaches for number of chronic disease conditions such as Crohn's disease, multiple Sclerosis, cancer, Alzheimer's disease, and chronic pain. Such conditions are frequently cited by the proponents of marijuana i.e. ...

    Comment?

  6. Swiss stocks - Factors to watch on May 14Read the original story w/Photo

    Sunday May 13 | Reuters

    The Swiss blue-chip SMI was seen opening 0.4 percent higher at 9,031 points on Monday, according to premarket indications by bank Julius Baer . The U.S. Food and Drug Administration on Friday expanded the use of Novartis AG's relapsing multiple sclerosis drug Gilenya to treat children and adolescents.

    Comment?

  7. Novartis's Gilenya gets FDA pediatric approvalRead the original story w/Photo

    Sunday May 13 | MarketWatch

    Novartis's multiple sclerosis drug Gilenya has been approved for use in pediatric patients by the U.S. Food and Drug Administration, the company and the regulator said. The drug, previously approved for patients older than 18, is the first disease-modifying therapy indicated for individuals aged between 10 and 18. Last Friday's approval comes after a phase 3 clinical trial showed Gilenya reduced relapse rates by approximately 82% over two years compared with interferon injections, the FDA said.

    Comment?

  8. Synthetic Biologics (SYN) Rating Increased to Buy at Zacks Investment ResearchRead the original story w/Photo

    Sunday May 13 | Daily Political

    ... Company is engaged in developing product candidates to treat pulmonary arterial hypertension, relapses in multiple sclerosis, cognitive dysfunction in multiple sclerosis, fibromyalgia and amyotrophic lateral sclerosis. Synthetic Biologics, Inc., ...

    Comment?

  9. Biogen (BIIB) Stock Rating Upgraded by ValuEngineRead the original story w/Photo

    Sunday May 13 | IntersportsWire

    ... The company offers TECFIDERA, AVONEX, PLEGRIDY, TYSABRI, ZINBRYTA, and FAMPYRA for the treatment of multiple sclerosis (MS); FUMADERM for the treatment of plaque psoriasis; and SPINRAZA to treat spinal muscular atrophy. Receive News & Ratings for ...

    Comment?

  10. JPMorgan Chase Analysts Give Sanofi (SAN) a a 72.00 Price TargetRead the original story w/Photo

    Sunday May 13 | The Breeze

    ... Type 1; and Aubagio, an oral immunomodulator and Lemtrada, a monoclonal antibody to treat multiple sclerosis. Receive News & Ratings for Sanofi Daily - Enter your email address below to receive a concise daily summary of the latest news and ...

    Comment?

  11. Managing depression and MSRead the original story

    Sunday May 13 | Holtville Tribune

    First, know you're not alone. Depression is very common among people with multiple sclerosis .

    Comment?

  12. Learn about MS at the libraryRead the original story

    Thursday May 10 | The West Milford Messenger

    Mood changes are among the most treatable symptoms of MS but continue to be under-diagnosed and under-treated. Hundreds of news cases are diagnosed each week in the United States, according to the Multiple Sclerosis Foundation.

    Comment?

  13. MediciNova Announces Opening of Investigational New Drug Application...Read the original story w/Photo

    Tuesday May 8 | Drugs.com

    ... current strategy is to focus on MN-166 (ibudilast) for neurological disorders such as progressive multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS) and substance dependence (e.g., alcohol use disorder, methamphetamine dependence, opioid ...

    Comment?

  14. Shipley man begins fundraising for USA coast-to-coast charity bike rideRead the original story w/Photo

    Sunday May 13 | Thetelegraphand Argus

    ... including Shipley's Cellar Trust, two causes close to his heart. He said: "My mum was diagnosed with Multiple Sclerosis whilst I was at school, and since then the condition has taken its toll on her. "I've seen first-hand the painful impact that MS ...

    Comment?

  15. Rapid magnetic resonance quantification on the brain: Optimization for clinical usage.Read the original story

    Sunday May 13 | CiteULike

    ... on the tissue (voxel size = 0.8 x 0.8 x 5 mm). As an example, the method was applied to a patient with multiple sclerosis in whom the diseased tissue could clearly be distinguished from healthy reference values. Additionally it was shown that, using ...

    Comment?

  16. The high density oxygen chamber at MS Action in Walthamstow.Read the original story w/Photo

    Sunday May 13 | Guardian-series.co.uk

    A charity has been gifted with a donation of 4,400 to aid the running costs of their oxygen treatment chamber. MS Action in Waltham Park Way, Walthamstow offers the chamber for free to people suffering from multiple sclerosis, autism, cerebral palsy and Parkinson's.

    Comment?

  17. Sanofi (SNY) Position Lessened by SG Americas Securities LLCRead the original story w/Photo

    Sunday May 13 | AmericanBankingNews.com

    ... Type 1; and Aubagio, an oral immunomodulator and Lemtrada, a monoclonal antibody to treat multiple sclerosis. Want to see what other hedge funds are holding SNY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Sanofi ...

    Comment?

  18. FDA Expands Approval of Gilenya (fingolimod) to Treat Multiple Sclerosis in Pediatric PatientsRead the original story w/Photo

    Friday May 11 | Drugs.com

    May 11, 2018 -- The U.S. Food and Drug Administration today approved Gilenya to treat relapsing multiple sclerosis in children and adolescents age 10 years and older. This is the first FDA approval of a drug to treat MS in pediatric patients.

    Comment?

  19. On My Mind: Cannabidiol (CBD) before weedRead the original story w/Photo

    Wednesday May 9 | The Martha's Vineyard Times

    ... only strong evidence for its use in other areas of medicine is in the treatment of neuropathic pain and multiple sclerosis-induced spasticity. But just because a thing isn't well enough studied doesn't mean that it doesn't work. People tell me all ...

    Comment?

  20. Mother and daughter's Montreal cafe is a labour of loveRead the original story w/Photo

    Sunday May 13 | CBC News

    ... always sure she'd be up to the challenge of running a small business. She was diagnosed with multiple sclerosis when she was still working in catering, and thought about taking a step back. "I felt maybe I should cut back, but then when I cut ...

    Comment?